Business
Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico
Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, will extend High-Volume Hemodiafiltration (HighVolumeHDF) access for patients in seven out of 10 centers in Mexico, by partnering with the country's Coordination of National Institutes of Health and Specialty Hospitals (CCINSHAE) to develop a pilot program that provides low-income patients without medical coverage in Mexico with access to hemodialysis therapies.
About this update from Fresenius Medical Care Ag
[{"type":"list","items":[{"val":[{"type":"text","content":"High-Volume Hemodiafiltration is used for the first time in seven out of 10 CCINSHAE centers in Mexico","length":102,"tagName":"p"}]},{"val":[{"type":"text","content":"In Mexico, 240 CCINSHAE patients are now being treated; more than 410 regular patients also treated","length":99,"tagName":"p"}]},{"val":[{"type":"text","content":"Fresenius Medical Care is committed to expanding HighVolumeHDF therapy to all markets where it is not already present, including the United States","length":146,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":347,"olType":false},{"type":"text","content":"BAD HOMBURG, Germany, July 3, 2025 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, will extend High-Volume Hemodiafiltration (HighVolumeHDF) access for patients in seven out of 10 centers in Mexico, by partnering with the country's Coordination of National Institutes of Health and Specialty Hospitals (CCINSHAE) to develop a pilot program that provides low-income patients without medical coverage in Mexico with access to hemodialysis therapies. ","length":555,"tagName":"p"},{"type":"text","content":"Fresenius Medical Care Mexico and CCINSHAE signed a two-year contract to enable the installation of the Fresenius Medical Care 5008S CorDiax technology in participating renal treatment centers in CCINCSHAE Centers in Mexico City (CDMX) and its metropolitan area, for a total of 150 systems in all.","length":297,"tagName":"p"},{"type":"text","content":""The groundbreaking pilot program, with its mission to provide chronic kidney disease patients with access to high quality treatments that were previously out of their reach, represents an important advancement in CKD in Mexico," said Edgar Robles, Fresenius Medical Care Mexico's Managing Director of Care Enablement Commercial Operations.","length":354,"tagName":"p"},{"type":"text","content":"This technology provides standard hemodialysis as well as HighVolumeHDF, a therapy that has demonstrated improved patient well-being while increasing cost-effectiveness in most health care systems.","length":197,"tagName":"p"},{"type":"text","content":"The initiative between Fresenius Medical Care and the CCINSHAE has recently provided HighVolumeHDF treatment t...